Correlation Between Brenmiller Energy and FibroBiologics, Common
Can any of the company-specific risk be diversified away by investing in both Brenmiller Energy and FibroBiologics, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brenmiller Energy and FibroBiologics, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brenmiller Energy Ltd and FibroBiologics, Common Stock, you can compare the effects of market volatilities on Brenmiller Energy and FibroBiologics, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brenmiller Energy with a short position of FibroBiologics, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brenmiller Energy and FibroBiologics, Common.
Diversification Opportunities for Brenmiller Energy and FibroBiologics, Common
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Brenmiller and FibroBiologics, is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Brenmiller Energy Ltd and FibroBiologics, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroBiologics, Common and Brenmiller Energy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brenmiller Energy Ltd are associated (or correlated) with FibroBiologics, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroBiologics, Common has no effect on the direction of Brenmiller Energy i.e., Brenmiller Energy and FibroBiologics, Common go up and down completely randomly.
Pair Corralation between Brenmiller Energy and FibroBiologics, Common
Given the investment horizon of 90 days Brenmiller Energy Ltd is expected to generate 0.9 times more return on investment than FibroBiologics, Common. However, Brenmiller Energy Ltd is 1.11 times less risky than FibroBiologics, Common. It trades about 0.04 of its potential returns per unit of risk. FibroBiologics, Common Stock is currently generating about -0.1 per unit of risk. If you would invest 74.00 in Brenmiller Energy Ltd on September 23, 2024 and sell it today you would earn a total of 1.00 from holding Brenmiller Energy Ltd or generate 1.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Brenmiller Energy Ltd vs. FibroBiologics, Common Stock
Performance |
| Timeline |
| Brenmiller Energy |
| FibroBiologics, Common |
Brenmiller Energy and FibroBiologics, Common Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Brenmiller Energy and FibroBiologics, Common
The main advantage of trading using opposite Brenmiller Energy and FibroBiologics, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brenmiller Energy position performs unexpectedly, FibroBiologics, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroBiologics, Common will offset losses from the drop in FibroBiologics, Common's long position.| Brenmiller Energy vs. Verde Clean Fuels | Brenmiller Energy vs. Smart Powerr Corp | Brenmiller Energy vs. Ormat Technologies | Brenmiller Energy vs. Tokyo Electric Power |
| FibroBiologics, Common vs. Fate Therapeutics | FibroBiologics, Common vs. Sana Biotechnology | FibroBiologics, Common vs. Caribou Biosciences | FibroBiologics, Common vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |